Inactive Instrument

Other languages Allena Pharmaceuticals, Inc.

Equities

ALNA

US0181191075

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Allena Pharmaceuticals, Inc. Went Out of Business	20/06/23
Interim Combined Hearing for Disclosure Statement and Plan Approved for Allena Pharmaceuticals, Inc.	12/04/23
Allena Pharmaceuticals, Inc. Terminates Employment of Louis Brenner as Chief Executive Officer	02/09/22
Allena Pharmaceuticals, Inc. Announces Management Changes	02/09/22
Allena Pharmaceuticals, Inc. Filed for Bankruptcy	02/09/22
Allena Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22
Allena Pharmaceuticals, Inc. Provides ALLN-346 Program Update	11/08/22
Allena Pharmaceuticals Says Enrollment Complete in Two Cohorts of Gout, Chronic Kidney Disease Treatment Study	19/07/22
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2A Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease	19/07/22
Allena Pharmaceuticals Postpones Special Meeting to Vote on Proposed Reverse Stock Split	05/07/22
Sector Update: Health Care Stocks Ending Near Session Highs	29/06/22
Sector Update: Health Care Stocks Helping Limit Wednesday Declines	29/06/22
Sector Update: Health Care	29/06/22
Allena Pharmaceuticals Nixes At-The-Market Offering Agreement; Shares Up After Hours	28/06/22
Allena Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Allena Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
Allena Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	30/03/22
Allena Pharmaceuticals' Coverage Dropped by Wedbush After Phase 3 Reloxaliase Study Terminated; Shares Plunge Pre-Bell	21/03/22
Allena Pharmaceuticals Says ALLN-346 Lowers High Uric Acid Symptoms in Mid-Stage Study; Shares Surge	04/01/22
Allena Pharmaceuticals to Explore Strategic Alternatives	04/01/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Allena Pharmaceuticals, Inc.

Equities

ALNA

US0181191075

Other languages

Filters